Texas 2023 - 88th Regular

Texas House Bill HB4561

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the establishment of the Alternative Mental Health Therapy Research Consortium and to certain plans, programs, and studies related to the provision of those alternative mental health therapies.

Impact

If enacted, HB 4561 would impact state laws by formalizing the research and practice of alternative therapies for mental health treatment within the state. It establishes a consortium that draws from various fields, including academia and mental health advocacy, to ensure comprehensive research is conducted. This could lead to the eventual development and implementation of alternative treatment options, highlighting a shift in mental health care policy that recognizes the potential benefits of psychedelics and other non-traditional therapies.

Summary

House Bill 4561 aims to establish the Texas Alternative Mental Health Therapy Research Consortium, which will focus on researching the efficacy of alternative mental health therapies, specifically psychedelic treatments and ketamine therapy, particularly for veterans. The proposal emphasizes the importance of exploring these alternative therapies in addressing mental health issues and facilitating better care for individuals, particularly those who have served in the military. The bill also includes provisions to establish a grant program for ketamine clinics and a plan for a voucher program for veterans to access ketamine therapy.

Sentiment

The general sentiment around HB 4561 appears to be cautiously optimistic among supporters, particularly within the veterans' community and mental health advocacy groups. Proponents believe that the bill could open new avenues for treatment options that are long overdue in mental health care practices. However, there could also be skepticism from various communities regarding the safety and ethical implications of utilizing psychedelic substances in therapeutic settings. Thus, the bill's discussion might involve a mix of advocacy for innovation while also addressing the necessary precautions.

Contention

Notable points of contention may include the ongoing debates surrounding the use of psychedelics in medical therapy, concerns about regulation and proper oversight, and the allocation of state resources towards these new treatment avenues. Critics might question the effectiveness and safety of such therapies based on historical misuses of psychedelics, while supporters will likely advocate for the potential benefits based on emerging research. Moreover, the success of this bill hinges on the eventual findings from the mandated studies, which could significantly influence future legislation related to mental health treatment approaches.

Companion Bills

No companion bills found.

Previously Filed As

TX HB1717

Modifies provisions relating to alternative therapies and treatments, including psilocybin

TX SB1682

Modifies provisions relating to alternative therapies and treatments, including psilocybin

TX SB1767

Modifies provisions relating to alternative therapies and treatments, including psilocybin

TX SB90

Modifies provisions relating to alternative therapies and treatments, including psilocybin

TX SR186

Creates the Task Force on Alternative Therapies for Veterans.

TX HB2922

Modifies provisions relating to alternative therapies

TX SB1454

Modifies provisions relating to alternative therapies

TX HB829

Modifies provisions relating to alternative therapies and treatments, including psilocybin

TX HB262

Creates provisions relating to alternative therapies for veterans with PTSD and traumatic brain injuries

TX S261

Regulating alternative healing therapies

Similar Bills

LA HB944

Creates the Louisiana Women's Health Consortium (EN NO IMPACT See Note)

TX SB728

Relating to an incentive program to promote beverage container recycling.

NJ S115

Establishes three-year nonpublic school pupil transportation pilot program in Ocean County to provide funding to county consortium of nonpublic schools that will assume responsibility for mandated nonpublic school busing.

MS HB314

Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of.

NJ S2139

Expands eligible grantees under New Jersey Civic Information Consortium; establishes provisions for tracking and reporting progress of grantee; requires grantee to post statement on Internet website.

MS SB2561

Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of.

TX HB2048

Relating to an incentive program to promote beverage container recycling.

NJ A3088

Establishes nonpublic school nursing services pilot program to provide funding to county consortium of nonpublic schools for nursing services.